GA Generic Assays develops, manufactures, distributes invitro diagnostic assays for systemic and organ specific autoimmune diseases, like rheumatic, neurologic, vascular, hepatic, renal and gastrointestinal diseases. These tests include cell based IFA, tissue sections, Dots, ELISA and rapid tests. We are the inventor and patent holder of CytoBead® assays, a one step diagnostic combining immunofluorescence for screening and microparticle based multiplex assay for differentiation and confirmation.
Press Releases
-
akiron® NEO
The akiron® NEO is a compact benchtop IFA analyzer for automated digital imaging of processed immunofluorescence slides to support the diagnosis of autoimmune diseases.
The akiron® NEO software based on artificial intelligence (AI) allows for an objective ANA / ANCA pattern recognition and intensity evaluation in about 35 seconds.* Validated akiron® NEO assay files support the standardized evaluation of a variety of immunofluorescence assays ranging from determination of antibodies against HEp-2 cells (ANA), granulocytes (ANCA), CLIFT (dsDNA), several tissues as well as against specific antigens using the CytoBead® technology. The powerful
easy-to-use akiron® NEO with a small footprint is indispensable for all routine diagnostic services in rheumatology and gastroenterology and not only for laboratories with limited bench space.
* ANA / ANCA / CLIFT
https://www.medipan.de/products/akiron-neo/
-
AKLIDES® Immunology
The AKLIDES® system is the world‘s first automated IFA analyzer for standardized, digital imaging of processed IFA slides. The AKLIDES® system is used to support the diagnosis of autoimmune diseases. It allows the analysis of up to five slides or 60 samples and designed for a high sample throughput.
The user-friendly AKLIDES® software enables objective ANA / ANCA pattern recognition in approx. 35 seconds per sample (ANA / ANCA / CLIFT). The simultaneous recording of the fluorescence intensity allows the determination of the end-titer from just one standard sample dilution, making the analysis of complex and cost-intensive dilution series obsolete.
Validated protocols and AKLIDES® assay files support the standardized evaluation of a large number of immunofluorescence analyzes for the determination of antibodies against HEp-2 cells (ANA), granulocytes (ANCA) and Crithidia luciliae (CLIFT, dsDNA), various tissue sections and against specific antigens using the CytoBead® technology. The results are clearly presented in well-arranged reports.
The powerful AKLIDES® system is easy and intuitive to use and indispensable for all diagnostic routine ervices in the fields of rheumatology and gastroenterology.
* ANA / ANCA / CLIFT
https://www.medipan.de/products/aklides-immunology/
-
DotDiver2.0
DotDiver2.0 is a compact benchtop immunoblot analyzer for fully automated processing and evaluation of LINE and Dot immunoblots to support the diagnosis of autoimmune diseases. Barcoded DotDiver2.0 test strips and cartridges ensure the correct combination of reagents and the quality assured handling of a wide range of immunoblots for rheumatology and gastroenterology in laboratory routine. Ready-to-use DotDiver2.0 reagents in pre-filled disposable cartridges minimize laborious hands-on time after manual sample application. The user-friendly DotDiver2.0 software guarantees the reliable evaluation of processed immunoblot test strips. The powerful easy-to-use DotDiver2.0 with a small footprint is indispensable for diagnostic routine services.
https://www.medipan.de/products/dotdiver2-0-2/
-
AKLIDES® nDNA
The AKLIDES® nDNA is an immunofluorescence assay (IFA) for the qualitative determination of IgG antibodies in human serum against native double-stranded DNA on Crithidia lucilliae hemoflaggelates.
The AKLIDES® nDNA is intended as an aid in the diagnosis of systemic lupus erythematosus (SLE) in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual processing and automated imaging using AKLIDES® or akiron® systems. The immunoassay is designed for professional in vitro diagnostic use only.
https://www.medipan.de/products/4282-aklides-ndna/
-
Anti-CCP
The Anti-CCP is a quantitative immunoassay for the determination of IgG antibodies against cyclic citrullinated peptides (CCP) in human serum. The Anti-CCP is intended as an aid in the diagnosis of rheumatoid arthritis (RA) in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
Product Highlights
- Use of synthetic, cyclic, citrullinated peptides
- Ready-to-use (exception: wash buffer) color and barcoded reagents
- Quality assured handling in routine laboratories
- Short incubation times (60 min / 30 min / 15 min at room temperature
- Quantitative determination of IgG antibody activity
- Calibrated using the international reference preparation IS 2723 of the Centers for Disease Control and Prevention (CDC)
- Excellent diagnostic sensitivity and specificity
- High precision within the measurement range
- CE certified
- Fully automatable
http://www.medipan.de/products/3665-anti-ccp/
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth?
YesIncluded in the Export Interest Directory?
YesBusiness Needs:
Distributor/Agent/RepresentativeProducts to be exported:
akiron® NEO - Automated digital IFA (device)Countries of Interest
Afghanistan, Albania, Algeria, Angola, Argentina, Armenia, Australia, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Chile, China, Cook Islands, Costa Rica, Denmark, Djibouti, Dominican Republic, Ecuador, El Salvador, Eritrea, Estonia, Fiji, Finland, France, Gabon, Gambia, Georgia, Germany, Ghana, Greenland, Grenada, Guadeloupe, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, Hong Kong, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Korea (North), Korea (South), Kosovo, Kuwait, Laos, Lebanon, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macau, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Montenegro, Mozambique, Namibia, Nauru, Nepal, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Romania, Russian Federation, Rwanda, Samoa, San Marino, Sao Tome and Principe, Saudi Arabia, Serbia, Seychelles, Sierra Leone, Singapore, Slovak Republic, Slovenia, Somalia, South Africa, Spain, Sri Lanka, Sudan, Suriname, Swaziland, Sweden, Switzerland, Syria, Tajikistan, Tanzania, Thailand, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan, Vanuatu, Vatican City State, Venezuela, Vietnam, Western Sahara, Yemen